0000927066-19-000165.txt : 20191104 0000927066-19-000165.hdr.sgml : 20191104 20191104164026 ACCESSION NUMBER: 0000927066-19-000165 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20191104 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20191104 DATE AS OF CHANGE: 20191104 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DAVITA INC. CENTRAL INDEX KEY: 0000927066 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 510354549 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-14106 FILM NUMBER: 191190378 BUSINESS ADDRESS: STREET 1: 2000 16TH STREET CITY: DENVER STATE: CO ZIP: 80202 BUSINESS PHONE: 310-536-2668 MAIL ADDRESS: STREET 1: 2000 16TH STREET CITY: DENVER STATE: CO ZIP: 80202 FORMER COMPANY: FORMER CONFORMED NAME: DAVITA HEALTHCARE PARTNERS INC. DATE OF NAME CHANGE: 20121107 FORMER COMPANY: FORMER CONFORMED NAME: DAVITA INC DATE OF NAME CHANGE: 20001005 FORMER COMPANY: FORMER CONFORMED NAME: TOTAL RENAL CARE HOLDINGS INC DATE OF NAME CHANGE: 19950524 8-K 1 form8-kreannouncemento.htm 8-K Document
false0000927066 0000927066 2019-11-04 2019-11-04
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 Form 8-K 
 CURRENT REPORT
 Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
 
Date of Report (date of earliest event reported): November 4, 2019
 
 
DAVITA INC.
(Exact name of registrant as specified in its charter)
 
 
DE
1-14106
51-0354549
(State or other jurisdiction
of incorporation)
(Commission File Number)
(IRS Employer
Identification No.)
 
2000 16th Street
Denver,
CO
80202
(Address of principal executive offices including Zip Code)
 
(720) 631-2100
(Registrant’s telephone number, including area code)
 
Not applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 240.425)
 
☑Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class:
 
Trading symbol(s):
 
Name of each exchange on which registered:
Common Stock, $0.001 par value
 
DVA
 
New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
☐Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐




Item 8.01 Other Events.
On November 4, 2019, the independent members of the Board of Directors of DaVita Inc. (the “Company”) unanimously approved an award of 2,500,000 premium-priced stock-settled stock appreciation rights (the “Premium-Priced Award”) to Javier Rodriguez, the Company’s Chief Executive Officer (“CEO”). The Premium-Priced Award is in lieu of any other long-term incentive awards for the next five years, as the Company does not intend to grant any additional equity awards to Mr. Rodriguez for five years following the date of grant of the Premium-Priced Award. The independent members of the Board of Directors also approved an amendment to the DaVita Inc. 2011 Incentive Award Plan, as amended and restated (the “2011 Incentive Plan,” and such proposed amendment, the “Amendment”), to permit the grant. The Amendment, which would allow the grant of the Premium-Priced Award, is contingent upon the approval of the Company’s stockholders. The Company expects to call a special meeting of the Company’s stockholders in early 2020 to seek such approval.
The Premium-Priced Award would be granted under the 2011 Incentive Plan, which currently provides that the maximum aggregate number of shares with respect to one or more awards that may be granted to any one person during any consecutive 12 month period is 2,250,000. If approved by the Company’s stockholders, the Amendment would allow the 2,500,000 grant to Mr. Rodriguez under the 2011 Incentive Plan.
The base price of the Premium-Priced Award is $67.80 per share (the “Base Price”). The Base Price is a 56% premium to the price of $43.42 per share, the closing price of the Company’s stock on the New York Stock Exchange on the day before Mr. Rodriguez assumed the role of CEO and a 20% premium to the price of $56.50 per share at which the Company purchased shares in its tender offer that closed on August 22, 2019. The Premium-Priced Award will vest 50% on the three-year anniversary of the grant date and 50% on the four-year anniversary of the grant date and the term of the Premium-Priced Award is five years. Mr. Rodriguez also will be required to hold any gain shares he receives from this grant until the five-year anniversary of the grant date. Compensation under this grant will only be realized if the Company’s stock price appreciates above the $67.80 base price over the term of the award.
In connection with the transition to a new CEO in 2019 and leading up to the decision to grant the Premium-Priced Award to Mr. Rodriguez, the Company and Board of Directors received and proactively sought feedback from the Company’s largest stockholders on the current structure of the executive compensation program. Following stockholder engagement, the independent Compensation Committee of the Board of Directors, in consultation with its independent compensation consultant, evaluated a number of alternatives to restructure compensation for Mr. Rodriguez in a way that continues to closely align him with Company and stock performance, particularly over the longer-term. They concluded that the Premium-Priced Award is closely aligned with long-term value creation at the Company as it is subject to a multi-year vesting period and contingent on significant stock price appreciation. Among the investors who provided input on the executive compensation program was Berkshire Hathaway, the Company’s largest stockholder, who has indicated support for the Premium-Priced Award and its intention to vote in favor of the Amendment.  
A copy of certain Questions & Answers Related to the Premium-Priced Award is attached as Exhibit 99.1 to this report.
Other Information
The Company plans to file with the Securities and Exchange Commission (the “SEC”), and furnish to its stockholders, a proxy statement in connection with the Amendment which would allow the grant of the Premium-Priced Award (the “Proxy Statement”) to be voted upon at a special meeting of stockholders. The Proxy Statement will contain important information about the Premium-Priced Award, the Amendment and related matters. STOCKHOLDERS OF THE COMPANY ARE URGED TO READ THE PROXY STATEMENT (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO) AND ANY OTHER RELEVANT DOCUMENTS THAT THE COMPANY WILL FILE WITH THE SEC WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE COMPANY, THE AMENDMENT AND THE PREMIUM-PRICED AWARD. Stockholders will be able to obtain free copies of these documents and other documents filed with the SEC by the Company through the website maintained by the SEC at www.sec.gov. In addition, stockholders will be able to obtain free copies of these documents from the Company by contacting the Company’s Investor Relations department by telephone at (310) 536-2585, or by going to the Company’s Investor Relations page on its website at investors.davita.com.
Participants in the Solicitation
The directors and executive officers of the Company will be deemed to be participants in the solicitation of proxies from the stockholders of the Company in connection with the Amendment which would allow the grant of the Premium-Priced Award. Information regarding the direct and indirect interests, by security holdings or otherwise of the Company’s directors and executive officers is set forth in the Company’s definitive proxy statement for the 2019 Annual Meeting of Stockholders filed with the SEC on April 29, 2019. To the extent that such participants’ holdings in the Company’s securities have changed since the amounts described in the definitive proxy statement for the Company’s 2019 Annual Meeting of Stockholders, such changes have been




reflected on Initial Statements of Beneficial Ownership on Form 3, Statements of Change in Ownership on Form 4 or Annual Statements of Changes in Beneficial Ownership of Securities on Form 5 filed with the SEC. These documents can be found on the SEC’s website at www.sec.gov or the Company’s website at investors.davita.com. Updated information regarding the identities of potential participants, and their direct or indirect interests, by security holdings or otherwise, will be set forth in the Proxy Statement.
Forward-Looking Statements
Certain statements in this report and the exhibit hereto, including statements regarding future plans of the Company, are forward-looking statements that are subject to risks and uncertainties. These forward-looking statements are based on management’s current expectations. Various important factors could cause actual results to differ materially, including the risks identified in our SEC filings. The Company disclaims any obligation to update any forward-looking statement contained in this report and the exhibit hereto.
 
Item 9.01. Financial Statements and Exhibits.
 
(d) Exhibits.
Exhibit
Number
Description
Questions & Answers Related to the Premium-Priced Award, dated November 4, 2019.
104.0
Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document.



 







SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
DAVITA INC.
 
 
 
Date: November 4, 2019
By:
/s/ Joel Ackerman
 
 
Joel Ackerman
 
 
Chief Financial Officer and Treasurer




 EX-99.1 2 exhbit991-qa.htm EXHIBIT 99.1 Exhibit
Exhibit 99.1

Q: Mr. Rodriguez’s performance has been impressive since he was appointed CEO - total stockholder return is up 42% - and he seems to be executing well against his strategy. Why is there a need to further incentivize him?
A: Mr. Rodriguez has already made meaningful progress against his plan but there is still more work to be done over the near- and long-term. The grant recognizes the significance of his promotion to Chief Executive Officer and seeks to create effective incentives for Mr. Rodriguez to pursue our new strategy and deliver on our goals. The Board believes that the long-term nature of this award, the premium price and the holding period create strong alignment with long-term, sustainable value creation.
Additionally the Company and Board received and proactively sought feedback from the Company’s largest stockholders on the current structure of the executive compensation program. Following stockholder engagement, the independent Compensation Committee of the Board of Directors, in consultation with its independent compensation consultant, evaluated a number of alternatives to restructure compensation for Mr. Rodriguez in a way that continues to closely align him with Company and stock performance, particularly over the longer-term. The Compensation Committee concluded that the Premium-Priced Award is closely aligned with long-term value creation at the Company as it is subject to a multi-year vesting period and contingent on significant stock price appreciation. Among the investors who provided input on the executive compensation program was Berkshire Hathaway, the Company’s largest stockholder, who has indicated support for the Premium-Priced Award and its intention to vote in favor of the Amendment.  

Q: Why are you issuing the Premium-Priced SSAR Award now, and not earlier when Mr. Rodriguez was appointed to the position of Chief Executive Officer?
A: Given that Mr. Rodriguez assumed the Chief Executive Officer role prior to the closing of the sale of DaVita Medical Group, and that the Company was considering meaningful share repurchases after the sale was completed, including potentially through a tender offer, the Board thought it was important for these developments to unfold before taking significant action regarding Mr. Rodriguez’s compensation. In addition, the Board wanted to incorporate feedback from our stockholder engagement program in connection with the transition to the new Chief Executive Officer and otherwise in order to further align the new Chief Executive Officer’s compensation with stockholder interests. Our Board is committed to soliciting input from and being responsive to our stockholders on a variety of topics, including compensation. Engaging with our investors is fundamental to our commitment to good governance and essential to evolving our compensation program and governance practices. The Premium-Priced SSAR Award is a product of that commitment, aligns with our philosophy of linking pay with performance, and creates the incentives needed during a time of leadership transition and strategic transformation.

Q: Why didn’t you wait until the regular compensation cycle (that is, early 2020) to issue this grant?
A: The Board felt it was important to make the grant and announcement in advance of the regular compensation cycle because it did not want to wait to incentivize Mr. Rodriguez under this new and powerful framework. There is a lot of work to be done in the early stages of this next phase of our evolution to benefit our patients, teammates, physician partners and healthcare community as a whole. Ensuring that Mr. Rodriguez has the proper long-term performance-based incentives in place to execute our multi-year strategy is critical to successfully achieving the full potential of our evolution in a way that drives stockholder value creation. The grant is contingent on receiving stockholder approval to lift our existing equity plan’s cap on aggregate equity grants to a single individual during any twelve-month period, which we will seek at a special meeting of stockholders in early 2020.

Q: Did you consider alternatives to incentivize the CEO? Why is this alternative the best for stockholders?
A: Yes, the Board considered other alternatives to incentivize the CEO, including normal, annual grants, as well as PSUs with multiple performance targets. The Board recognizes that a multi-year grant is atypical, but at this stage in the Company’s evolution, the Board felt the Premium-Priced SSARs were the best alternative for stockholders because (1) our new CEO will have the opportunity to realize significant financial benefit if he is able to execute




successfully on our new strategies, and (2) the Board wanted to give our CEO a strong incentive to drive meaningful value to stockholders.

Q: Will this type of grant be made to other executives?
A: The Board does not intend to make this type of grant to other executives. The Board expects to continue to incentivize other executives with annual grants, which will include both time- and performance-based equity incentives.

Q: If the grant is out-of-the-money at vesting, will you grant new equity to the Chief Executive Officer?
A: No, the Board does not intend to grant any additional equity awards to the Chief Executive Officer during the five-year life of the Premium-Priced SSAR Award. The purpose of this performance-based grant is to incentivize Mr. Rodriguez to achieve his strategic objectives and deliver meaningful stockholder returns over a five-year period as our new Chief Executive Officer. Mr. Rodriguez will not realize significant value from this grant if he is not able to deliver meaningful returns to stockholders.
The Chief Executive Officer will continue to receive his base salary, which creates some certainty in base levels of compensation during the award’s term, and will also be eligible to receive an annual short term incentive award that is designed to align compensation with the achievement of annual objectives that are informed by and aligned with our strategy over time. The Compensation Committee will continue to review our program and practices to ensure that they appropriately reflect our evolving business, and our incentive and retention needs. However, the Board remains committed to closely linking pay with performance, to promote sustainable growth in stock price.

Q: Have you engaged with the Company’s stockholders, including the Company’s largest stockholder, Berkshire Hathaway, to get their input on the Premium-Priced SSAR Award?
A: In connection with the transition to a new CEO in 2019 and leading up to the decision to grant the Premium-Priced SSAR Award to him, the Company and Board of Directors received and proactively sought feedback from the Company’s largest stockholders on the current structure of the executive compensation program. Following stockholder engagement, the independent Compensation Committee of the Board, in consultation with its independent compensation consultant, evaluated a number of alternatives to restructure compensation for Mr. Rodriguez in a way that continues to closely align him with Company and stock performance, particularly over the longer-term. They concluded that the Premium-Priced SSAR Award is closely aligned with long-term value creation at the Company as it is subject to a multi-year vesting period and contingent on significant stock price appreciation. Among the investors who provided input on the executive compensation program was Berkshire Hathaway, the Company’s largest stockholder, who has indicated support for the Premium-Priced SSAR Award and its intention to vote in favor of the related amendment to the 2011 Plan.

Q: How did you select the number of SSARs to be granted?
A: The Compensation Committee determined the number of SSARs to be granted based on the expected grant value of equity awards that would otherwise have been granted to our Chief Executive Officer over a five-year period, based on our historical grant practices and expected equity grant patterns. As part of our grant practices, the Compensation Committee compares our equity compensation grants with those of our peer companies in order to provide compensation opportunities that it believes are consistent with companies in the broader market with which we compete for executive talent. The Compensation Committee believes this grant would have a Black-Scholes value (on an annual basis over five years) on the lower end of equity grants typically made to the CEOs of our peer companies. The Compensation Committee also considered multi-year equity awards offered by other companies in determining the number of SSARs to be granted.




Q: One issue with multi-year grants is that they take away the ability of the Board to make adjustments to compensation based on performance and other market conditions. What will happen if DaVita or the market experience a big downturn? How will the CEO be incentivized?
A: The Premium-Priced SSARs have a five-year life, and consequently, even if DaVita’s stock, or the market, experiences a big downturn, there could still be enough time prior to expiration for the stock price to recover. Furthermore, our CEO receives a fixed base salary and an annual short term incentive tied to various performance criteria, which creates the opportunity for meaningful compensation even if there is little or no value in the Premium-Priced SSARs. Finally, our Board focuses on how the structure of the grant aligns realizable pay with company performance, including stock price performance, which is a hallmark of all of our compensation programs. The structure of this award is such that Mr. Rodriguez will not realize meaningful value from this grant if he is not able to deliver strong operating performance, which we believe over time will be reflected in strong stock price performance.

Q: How did you select the premium?
A: Given that we recently completed a modified “Dutch auction” tender for our stock, the Board felt that the base price (similar to an option’s exercise price) should be set at a premium to the tender clearing price, which was a meaningful indicator of stockholder perception of value. By setting the base price ($67.80) at a 20% premium to the tender clearing price of $56.50, Mr. Rodriguez will have to create significant value for our stockholders before he is able to realize meaningful value from this award. In addition, the base price is a significant premium to the stock price when Mr. Rodriguez assumed the Chief Executive Officer role. Specifically, the premium represented by the base price, compared to those benchmarks, is as follows:
 
Date
Price
Premium
Stock price day before Mr. Rodriguez assumed CEO role
May 31, 2019
$43.42
56%
Tender clearing price
Aug. 22, 2019
$56.50
20%
It is important to note that the $67.80 base price (similar to an option exercise price) is not a performance hurdle triggering exercisability at some lower price, but that Mr. Rodriguez only participates in the upside above this price.

Q: Why is there a holding period for the full term of the SSAR Award?
A: The Premium-Priced SSAR Award includes a holding period requiring that the Chief Executive Officer hold the shares acquired upon exercise until the five-year anniversary of the grant date, that is, for the full term of the award, subject to the lapse of the holding period upon a change in control of the Company or due to Mr. Rodriguez’s death or termination due to disability. The Board believes that it is important that any stock price gains from strategies implemented by the Chief Executive Officer also be sustainable. The Board believes that the holding period requirement creates significant alignment between our Chief Executive Officer’s actions and the long-term sustainability of our stock price. It is important to note that we also have a specific stock ownership requirement, which for the Chief Executive Officer is equal to 6.0 times base salary, further aligning his interests with those of our stockholders.

Q: Why aren’t there other performance criteria?
A: Given the long-term nature of this award and the premium base price, the Board believes that a variety of other performance measures (earnings per share growth, margin maintenance, cash flow generation, returns on invested capital) must be achieved and sustained over a long period of time in order to achieve a meaningful increase in the stock price above the base price and for the Chief Executive Officer to consequently realize significant value from this award after the end of the five-year period. Mr. Rodriguez’s annual short term incentive will continue to be subject to performance criteria. Mr. Rodriguez will not realize meaningful value, or potentially any value from this grant, if he is not able to deliver meaningful and sustained returns to stockholders, which involves the achievement




of a broad set of performance measures. In addition, setting absolute financial goals could be heavily impacted by macroeconomic or regulatory pressures, whereas a longer-term share price based award can be a better measure of performance if and when strategic priorities change. For example, the Company may have to make significant operating expenditures to prepare for integrated care initiatives associated with the PATIENTS Act (or functionally equivalent legislation), if it becomes law. This could have the effect of suppressing financial results in the near term, but creating significant financial opportunity in the longer-term.

Q: Given that some stockholders have previously expressed concerns regarding large front-loaded multi-year grants, why did the Board go down this path?
A: The CEO does not benefit from this grant without delivering significant value creation to stockholders, and he must retain the net shares realized until after the five-year anniversary of the grant date. The Board believes that many of our stockholders would prefer forms of compensation that are heavily weighted toward the most direct form of alignment with stockholder value creation, such as an increasing stock price. This compensation structure reflects the feedback of our stockholders from our stockholder engagement program, including from Berkshire Hathaway, and the Board believes that it will strongly incentivize Mr. Rodriguez to create long-term, sustainable stockholder value.



EX-101.SCH 3 dva-20191104.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001000 - Document - Document and Entity Information Document and Entity Information link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 4 dva-20191104_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 5 dva-20191104_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 6 dva-20191104_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Cover page. Title of 12(b) Security Title of 12(b) Security Document Type Document Type Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, City or Town Entity Address, City or Town Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre-commencement Tender Offer Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Entity Emerging Growth Company Entity Emerging Growth Company Entity Central Index Key Entity Central Index Key Amendment Flag Amendment Flag Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name EX-101.PRE 7 dva-20191104_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT JSON 8 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "form8-kreannouncemento.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "calculationLink": { "local": [ "dva-20191104_cal.xml" ] }, "definitionLink": { "local": [ "dva-20191104_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml", "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml" ] }, "inline": { "local": [ "form8-kreannouncemento.htm" ] }, "labelLink": { "local": [ "dva-20191104_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "dva-20191104_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml" ] }, "schema": { "local": [ "dva-20191104.xsd" ], "remote": [ "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd", "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd", "http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd", "http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd", "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd", "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 23, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2019-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 97, "memberCustom": 0, "memberStandard": 0, "nsprefix": "dva", "nsuri": "http://www.davita.com/20191104", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "form8-kreannouncemento.htm", "contextRef": "D2019Q3NOV4-NOV4", "decimals": null, "first": true, "lang": "en-US", "name": "dei:Security12bTitle", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001000 - Document - Document and Entity Information Document and Entity Information", "role": "http://www.davita.com/role/DocumentAndEntityInformationDocumentAndEntityInformation", "shortName": "Document and Entity Information Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "form8-kreannouncemento.htm", "contextRef": "D2019Q3NOV4-NOV4", "decimals": null, "first": true, "lang": "en-US", "name": "dei:Security12bTitle", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.davita.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.davita.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cover page.", "label": "Cover page." } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.davita.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.davita.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.davita.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.davita.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.davita.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.davita.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.davita.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.davita.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.davita.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.davita.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.davita.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.davita.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.davita.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.davita.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.davita.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.davita.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.davita.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.davita.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.davita.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.davita.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } XML 9 FilingSummary.xml IDEA: XBRL DOCUMENT 3.19.3 html 1 97 1 false 0 0 false 0 false false R1.htm 0001000 - Document - Document and Entity Information Document and Entity Information Sheet http://www.davita.com/role/DocumentAndEntityInformationDocumentAndEntityInformation Document and Entity Information Document and Entity Information Cover 1 false false All Reports Book All Reports form8-kreannouncemento.htm dva-20191104.xsd dva-20191104_cal.xml dva-20191104_def.xml dva-20191104_lab.xml dva-20191104_pre.xml exhbit991-qa.htm http://xbrl.sec.gov/dei/2019-01-31 true true XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 form8-kreannouncemento_htm.xml IDEA: XBRL DOCUMENT 0000927066 2019-11-04 2019-11-04 false 0000927066 8-K 2019-11-04 DAVITA INC. DE 1-14106 51-0354549 2000 16th Street Denver, CO 80202 720 631-2100 false true false false Common Stock, $0.001 par value DVA NYSE false EXCEL 13 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end ZIP 14 0000927066-19-000165-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000927066-19-000165-xbrl.zip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end XML 15 R1.htm IDEA: XBRL DOCUMENT v3.19.3
Document and Entity Information Document and Entity Information
Nov. 04, 2019
Cover page.  
Title of 12(b) Security Common Stock, $0.001 par value
Document Type 8-K
Document Period End Date Nov. 04, 2019
Entity Registrant Name DAVITA INC.
Entity Incorporation, State or Country Code DE
Entity File Number 1-14106
Entity Tax Identification Number 51-0354549
Entity Address, Address Line One 2000 16th Street
Entity Address, City or Town Denver,
Entity Address, State or Province CO
Entity Address, Postal Zip Code 80202
City Area Code 720
Local Phone Number 631-2100
Written Communications false
Soliciting Material true
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Entity Central Index Key 0000927066
Amendment Flag false
Trading Symbol DVA
Security Exchange Name NYSE
XML 16 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}